Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2024-02-29 00:00:00 ET · period of report 2024-02-27 · accession 0001415889-24-005883 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-29 | 2024-02-27 | KNSA | Paolini John F. | Chief MEDICAL Off | S - Sale+OE | $21.03 | -10.2K | 44.9K | -18% | -$213.6K |
| D | 2024-02-29 | 2024-02-27 | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | $1.86 | +10.2K | 55.0K | +23% | +$18.9K |
| D | 2024-02-29 | 2024-02-27 | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | $0.00 | -10.2K | 101.1K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2024-02-27 | S | D | 10,156 | $21.03 | 44,892 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging from $21.00 to $21.09. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 2 | Common | Class A Common Share | 2024-02-27 | M | A | 10,156 | $1.86 | 55,048 | D | — | — | |
| 3 | Derivative | Share Option | 2024-02-27 | M | D | 10,156 | $0.00 | 101,061 | D | $1.86 · — to 2026-09-13 | 10,156 Class A Common Shares | (F3) The option is fully vested and exercisable. |